POWERFUL NEXT GENERATION INTRACELLULARLY DELIVERY PLATFORM TO ACCELERATE MACROMOLECULE THERAPEUTIC DISCOVERY

 

Tana-porter™

Taking full advantage of the endocytic pathway, Tana-porter™ is an extremely safe and efficient endosomal translocation & release platform. Tana-Porter™ achieved:
>95% cell viability post exposure,
>90% payload release, and
rivals viral vector AAV in transfection.

cell endosomal release-web.png
 
Medicine Prescription

OUR VISION

We aim to dramatically accelerate drug discovery with our powerful next generation intracellular delivery platform, TANA-Porter™

 

OUR IMPACT

Tana-Porter™ can enhance the efficacy of currently available intracellularly active drugs i.e. chemotherapeutics thereby reducing dosage requirements and thus decrease toxicity and side effects profile. 

Tana-porter™ makes it possible for biologics and macromolecules such as DNA, various RNA, and proteins to reach their intracellular target and realize their therapeutic potentials.

 

6200 Stoneridge Mall Rd. Suite 300, Pleasanton, CA 94588

©2020 by Tanatherapeutics.com